Sinovac enters partnership to begin Omicron-specific Covid-19 booster trial
The trial will enrol 300 subjects to assess the safety and immunogenicity of Sinovac's booster vaccine.

The trial will enrol 300 subjects to assess the safety and immunogenicity of Sinovac's booster vaccine.
Clinical Trials Arena asks Dr Anthony Fauci about the biggest challenges to selecting long Covid-19 trial endpoints during a National…
ByIncreased neutralising antibody levels against all variants, including Omicron BA2, and memory response were observed in subjects.
The clinical trials sector can make small changes to make transgender, nonbinary individuals feel safe to join studies.
ByStage two of the Phase III Covid-19 vaccine trial enrolled more than 13,000 subjects aged 18 years and older.
Concept: US-based startup SAVRpak has introduced SAVRpak Drop-In, a moisture control technology that claims to triple the shelf life and…
For the monovalent 30µg and 60µg vaccines, the GMRs were 2.23 and 3.15, respectively.
The network will progress to support critical research capacity among a national network of over 60 sites with the funding.
Thank you for subscribing to Clinical Trials Arena